:: Altroz - News Magazine HTML Template ::

Language:

Spikevax News

Moderna Faces $1 Billion Net Loss in Q1 2025 Amid Declining COVID-19 Vaccine Sales

James Carter 01 May, 2025

Moderna reports a $1 billion net loss in Q1 2025 due to decreased COVID-19 vaccine sales, with Spikevax® generating $84 million. CEO Stephane Bancel remains optimistic about future...

Spikevax News

Moderna Faces $1 Billion Net Loss in Q1 2025 Amid Declining COVID-19 Vaccine Sales

Popular News

Asian Markets Show Mixed Reactions Following Trump's Comments on China Tariffs

Aramco Reports a 12% Drop in 2024 Net Income to $106.2B Amid Global Oil Demand Surge

Wall Street Ends Mixed Amid Volatile Trading and Jobs Report Scrutiny

EU Slams Apple and Meta with Hefty €700M Fines for Breaking Competition Rules

France's Trade Deficit Narrows to €6.25 Billion in March, Signaling Economic Resilience

European Markets Show Mixed Signals in Premarket Ahead of Key Economic Reports

Indian Government to Acquire 48.99% Stake in Vodafone Idea, Converting Rs 36,950 Crore Spectrum Dues into Equity

India-UK Free Trade Agreement Faces Delays Amidst Unresolved Critical Issues

Newsletter

Subscribe Newsletter!

Privacy Policy

Terms & Conditions

Contact Us